Amplitude Surgical’s Foot and Ankle Sales Continue Growth Despite Pandemic

By Mike Evers

Amplitude Surgical’s Foot and Ankle Sales Continue Growth Despite Pandemic

Amplitude Surgical reported FY 3Q21 orthopedic revenue of USD $33.7 million, +3.7% vs. 3Q20. Compared to FY 3Q19, the pre-pandemic period ending in March 2019, sales declined -6.4%.

The company continues dealing with the fallout of COVID’s third wave and resulting surgical restrictions. In the first half of April 2020, Amplitude observed an acceleration of the public health crisis in its key markets of France, Germany and Brazil. The company’s Novastep foot and ankle business posted nearly +31% growth for the quarter, and over 60% growth in the U.S.


Revenue Data

All revenue data is provided in USD millions unless otherwise noted. Sales and growth rates are estimated on an as-reported basis.

Segment Sales

3Q21 3Q20 $ Chg % Chg
Joint Replacement $27.8 $27.7 $0.2 0.7%
Knees $16.0 $16.2 ($0.2) (1.5%)
Hips $11.9 $11.4 $0.4 3.7%
Trauma $4.1 $3.2 $1.0 30.8%
Sports Medicine $1.0 $1.0 $0.0 0.2%
Orthobiologics $0.7 $0.6 $0.1 7.9%
Total $33.7 $32.5 $1.2 3.7%
9m21 9m20 $ Chg % Chg
Joint Replacement $74.2 $79.6 ($5.4) (6.8%)
Knees $43.0 $46.8 ($3.8) (8.1%)
Hips $31.2 $32.8 ($1.6) (5%)
Trauma $11.6 $9.0 $2.6 28.4%
Sports Medicine $2.4 $2.8 ($0.4) (13.4%)
Orthobiologics $1.5 $1.9 ($0.3) (18.3%)
Total $89.7 $93.3 ($3.6) (3.8%)

Geographic Sales

3Q21 3Q20 $ Chg % Chg
France $22.9 $21.6 $1.3 5.9%
International $10.8 $10.9 ($0.1) (0.8%)
Subsidiaries $8.2 $7.6 $0.6 8.1%
Distributors $2.5 $3.2 ($0.7) (21.7%)
Total $33.7 $32.5 $1.2 3.7%
9m21 9m20 $ Chg % Chg
France $59.0 $58.7 $0.3 0.6%
International $30.6 $34.6 ($3.9) (11.3%)
Subsidiaries $23.4 $25.2 ($1.7) (6.8%)
Distributors $7.2 $9.4 ($2.2) (23.4%)
Total $89.7 $93.3 ($3.6) (3.8%)

Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.

Product Labels: Trauma Ankle/Foot/Toe

Tags: Revenue Report